Features and Outcomes of 280 Patients With Idiosyncratic Drug-induced Liver Injury: The REFHEPS Prospective Study
Clinical Gastroenterology and Hepatology · 2025
DOI: 10.1016/j.cgh.2025.10.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2025. Verfasst von Lucy Meunier und 23 weiteren Autor:innen. Beteiligte Einrichtung: Hepatology and Liver Transplantation Unit, Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France; Institute for Regenerative Medi…. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury. Die Arbeit nennt 22 Literaturangaben. Gefördert von: French Association of Liver Research.
Abstract (Originalsprache)
BACKGROUND & AIMS: In October 2021, France and Belgium launched a joint prospective drug-induced liver injury (DILI) network (Réseau d'Etude Francophone de l'Hépatotoxicité des Produits de Santé - REFHEPS), which aims to collect liver toxicity data. Here, we present the clinical characteristics, outcome, histological features, and culprit drugs responsible for cases with DILI collected from January 2022 to June 30, 2024. METHODS: Demographics, clinical presentation, histological findings, and outcome of prospectively recruited cases with DILI in the REFHEPS were analyzed. Case definition and severity of DILI were established according to the criteria of RUCAM and Drug-Induced Liver Injury Network (DILIN) criteria. RESULTS: A total of 322 cases met the inclusion criteria for DILI, including 42 cases related to paracetamol. The current study focused on the 280 patients with idiosyncratic DILI. Our study highlights sex- and age-related differences: females were younger (57 vs 59.7 years; P = .047) and more likely to develop hepatocellular DILI (60% vs 45.5%; P = .02), whereas disease severity and outcomes were similar across sexes. In patients over 65 years, DILI had a later onset, was more cholestatic, and tended to be less symptomatic. A major finding is that anticancer drugs, particularly immune checkpoint inhibitors, account for most DILI cases (68.9%). CONCLUSIONS: The REFHEPS registry collected 322 cases in 2.5 years. The study of the 280 idiosyncratic cases of DILI shows sex and age-related differences as reported in previous registries. The most significant difference compared with older registries is the predominance of anticancer drugs causing liver injury, demonstrating the emergence of "new" side effects associated with the use of innovative therapies, especially immune checkpoint inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hepatology and Liver Transplantation Unit, Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France; Institute for Regenerative Medicine and Biotherapy (IRMB), Saint Eloi Hospital, Montpellier Universit…
- REFHEPS, Montpellier, France; Department of Hepato-Gastroenterology, Cliniques Universitaires Saint-Luc et Institut de Recherche Clinique (IREC), Université Catholique de Louvain, Brussels, Belgium.
- REFHEPS, Montpellier, France; AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, INSERM Unit 1193, Univ Paris-Sud, Université Paris-Saclay, FHU Hépatinov, Villejuif, France.
- Department of Hepatology, Lyon Liver Institute, Hospices Civils de Lyon, Lyon, France.
- Department of Gastroenterology and Hepatology, Hôpital Universitaire de l'Archet, Nice, France.
- Digestive Diseases Federation, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Förderung
- French Association of Liver Research
Zitieren
APA
Meunier, L., Delire, B., De Martin, E., Lebossé, F., Anty, R., Dumortier, J., Houssel-Debry, P., Delwaide, J., Duclos-Vallee, J. C., Lutu, A., Lemoinne, S., Roux, O., Péron, J. M., Saviano, A., Abergel, A., Prost, A., Hountondji, L., Thabut, D., Dharancy, S., …, & REFHEPS Group (2025). Features and Outcomes of 280 Patients With Idiosyncratic Drug-induced Liver Injury: The REFHEPS Prospective Study. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2025.10.024
Vancouver
Meunier L, Delire B, De Martin E, Lebossé F, Anty R, Dumortier J, et al. Features and Outcomes of 280 Patients With Idiosyncratic Drug-induced Liver Injury: The REFHEPS Prospective Study. Clinical Gastroenterology and Hepatology. 2025. doi:10.1016/j.cgh.2025.10.024
BibTeX
@article{Meunier2025,
author = {Meunier, Lucy and Delire, Bénédicte and De Martin, Eleonora and Lebossé, Fanny and Anty, Rodolphe and Dumortier, Jérôme and Houssel-Debry, Pauline and Delwaide, Jean and Duclos-Vallee, Jean-Charles and Lutu, Alina and Lemoinne, Sara and Roux, Olivier and Péron, Jean-Marie and Saviano, Antonio and Abergel, Armand and Prost, Ardavan and Hountondji, Lina and Thabut, Dominique and Dharancy, Sébastien and Antonini, Teresa and Zahhaf, Amel and Horsmans, Yves and Larrey, Dominique and REFHEPS Group, REFHEPS Group},
title = {Features and Outcomes of 280 Patients With Idiosyncratic Drug-induced Liver Injury: The REFHEPS Prospective Study},
journal = {Clinical Gastroenterology and Hepatology},
year = {2025},
doi = {10.1016/j.cgh.2025.10.024}
}
EUVIMED